| Year |
Citation |
Score |
| 2018 |
Ursini G, Punzi G, Chen Q, Marenco S, Robinson JF, Porcelli A, Hamilton EG, Mitjans M, Maddalena G, Begemann M, Seidel J, Yanamori H, Jaffe AE, Berman KF, Egan MF, et al. Convergence of placenta biology and genetic risk for schizophrenia. Nature Medicine. PMID 29808008 DOI: 10.1038/S41591-018-0021-Y |
0.318 |
|
| 2014 |
Weickert TW, Terrazas A, Bigelow LB, Apud JA, Egan MF, Weinberger DR. Perceptual Category Judgment Deficits are Related to Prefrontal Decision Making Abnormalities in Schizophrenia. Frontiers in Psychiatry. 4: 184. PMID 24432006 DOI: 10.3389/fpsyt.2013.00184 |
0.446 |
|
| 2013 |
Weickert TW, Mattay VS, Das S, Bigelow LB, Apud JA, Egan MF, Weinberger DR, Goldberg TE. Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease. Schizophrenia Research. 149: 162-6. PMID 23830543 DOI: 10.1016/j.schres.2013.06.028 |
0.397 |
|
| 2012 |
Kopald BE, Mirra KM, Egan MF, Weinberger DR, Goldberg TE. Magnitude of impact of executive functioning and IQ on episodic memory in Schizophrenia. Biological Psychiatry. 71: 545-51. PMID 22265665 DOI: 10.1016/j.biopsych.2011.11.021 |
0.419 |
|
| 2011 |
Egan MF, Cannon TD. Intermediate Phenotypes in Genetic Studies of Schizophrenia Schizophrenia: Third Edition. 289-310. DOI: 10.1002/9781444327298.ch14 |
0.316 |
|
| 2010 |
Weickert TW, Goldberg TE, Egan MF, Apud JA, Meeter M, Myers CE, Gluck MA, Weinberger DR. Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings. Biological Psychiatry. 67: 948-55. PMID 20172502 DOI: 10.1016/J.Biopsych.2009.12.027 |
0.414 |
|
| 2009 |
Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V, Lipska BK, Hyde TM, Song J, Rujescu D, Giegling I, Mayilyan K, Proust MJ, Soghoyan A, Caforio G, ... ... Egan MF, et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nature Medicine. 15: 509-18. PMID 19412172 DOI: 10.1038/Nm.1962 |
0.65 |
|
| 2009 |
Shapiro DI, Marenco S, Spoor EH, Egan MF, Weinberger DR, Gold JM. The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings. Schizophrenia Research. 112: 136-42. PMID 19410430 DOI: 10.1016/J.Schres.2009.04.007 |
0.375 |
|
| 2009 |
Weickert TW, Goldberg TE, Callicott JH, Chen Q, Apud JA, Das S, Zoltick BJ, Egan MF, Meeter M, Myers C, Gluck MA, Weinberger DR, Mattay VS. Neural correlates of probabilistic category learning in patients with schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1244-54. PMID 19176832 DOI: 10.1523/Jneurosci.4341-08.2009 |
0.636 |
|
| 2008 |
Kempf L, Nicodemus KK, Kolachana B, Vakkalanka R, Verchinski BA, Egan MF, Straub RE, Mattay VA, Callicott JH, Weinberger DR, Meyer-Lindenberg A. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. Plos Genetics. 4: e1000252. PMID 18989458 DOI: 10.1371/journal.pgen.1000252 |
0.677 |
|
| 2008 |
Hyde TM, Deep-Soboslay A, Iglesias B, Callicott JH, Gold JM, Meyer-Lindenberg A, Honea RA, Bigelow LB, Egan MF, Emsellem EM, Weinberger DR. Enuresis as a premorbid developmental marker of schizophrenia. Brain : a Journal of Neurology. 131: 2489-98. PMID 18669483 DOI: 10.1093/Brain/Awn167 |
0.637 |
|
| 2008 |
Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophrenia Research. 105: 78-85. PMID 18617370 DOI: 10.1016/J.Schres.2008.05.027 |
0.324 |
|
| 2008 |
Ceaser AE, Goldberg TE, Egan MF, McMahon RP, Weinberger DR, Gold JM. Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? Biological Psychiatry. 64: 782-8. PMID 18597738 DOI: 10.1016/J.Biopsych.2008.05.009 |
0.34 |
|
| 2008 |
Matsumoto M, Straub RE, Marenco S, Nicodemus KK, Matsumoto S, Fujikawa A, Miyoshi S, Shobo M, Takahashi S, Yarimizu J, Yuri M, Hiramoto M, Morita S, Yokota H, Sasayama T, ... ... Egan MF, et al. The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 105: 6133-8. PMID 18413613 DOI: 10.1073/pnas.0710717105 |
0.633 |
|
| 2008 |
Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Molecular Psychiatry. 13: 709-16. PMID 18347599 DOI: 10.1038/mp.2008.32 |
0.321 |
|
| 2008 |
Meyer-Lindenberg A, Nicodemus KK, Egan MF, Callicott JH, Mattay V, Weinberger DR. False positives in imaging genetics. Neuroimage. 40: 655-61. PMID 18201908 DOI: 10.1016/j.neuroimage.2007.11.058 |
0.555 |
|
| 2008 |
Nicodemus KK, Marenco S, Batten AJ, Vakkalanka R, Egan MF, Straub RE, Weinberger DR. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Molecular Psychiatry. 13: 873-7. PMID 18195713 DOI: 10.1038/sj.mp.4002153 |
0.416 |
|
| 2008 |
Goldberg TE, Iudicello J, Russo C, Elvevåg B, Straub R, Egan MF, Weinberger DR. BDNF Val66Met polymorphism significantly affects d' in verbal recognition memory at short and long delays. Biological Psychology. 77: 20-4. PMID 17988784 DOI: 10.1016/j.biopsycho.2007.08.009 |
0.353 |
|
| 2008 |
Diaz-Asper CM, Goldberg TE, Kolachana BS, Straub RE, Egan MF, Weinberger DR. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biological Psychiatry. 63: 72-9. PMID 17707347 DOI: 10.1016/j.biopsych.2007.03.031 |
0.425 |
|
| 2008 |
Honea RA, Meyer-Lindenberg A, Hobbs KB, Pezawas L, Mattay VS, Egan MF, Verchinski B, Passingham RE, Weinberger DR, Callicott JH. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biological Psychiatry. 63: 465-74. PMID 17689500 DOI: 10.1016/j.biopsych.2007.05.027 |
0.623 |
|
| 2008 |
Buckholtz JW, Callicott JH, Kolachana B, Hariri AR, Goldberg TE, Genderson M, Egan MF, Mattay VS, Weinberger DR, Meyer-Lindenberg A. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Molecular Psychiatry. 13: 313-24. PMID 17519928 DOI: 10.1038/sj.mp.4002020 |
0.552 |
|
| 2007 |
Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, Mayhew MB, Vakkalanka RK, Kolachana BS, Kleinman JE, Weinberger DR. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Molecular Psychiatry. 12: 854-69. PMID 17767149 DOI: 10.1038/sj.mp.4001988 |
0.651 |
|
| 2007 |
Hyde TM, Goldberg TE, Egan MF, Lener MC, Weinberger DR. Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls. The British Journal of Psychiatry : the Journal of Mental Science. 191: 120-5. PMID 17666495 DOI: 10.1192/bjp.bp.106.026773 |
0.457 |
|
| 2007 |
Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, Egan MF, Mattay VS, Meyer-Lindenberg A, Weinberger DR, Callicott JH. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proceedings of the National Academy of Sciences of the United States of America. 104: 12536-41. PMID 17636131 DOI: 10.1073/pnas.0610125104 |
0.634 |
|
| 2007 |
Sei Y, Ren-Patterson R, Li Z, Tunbridge EM, Egan MF, Kolachana BS, Weinberger DR. Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms. Molecular Psychiatry. 12: 946-57. PMID 17440436 DOI: 10.1038/Sj.Mp.4001994 |
0.459 |
|
| 2007 |
Buckholtz JW, Meyer-Lindenberg A, Honea RA, Straub RE, Pezawas L, Egan MF, Vakkalanka R, Kolachana B, Verchinski BA, Sust S, Mattay VS, Weinberger DR, Callicott JH. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1584-93. PMID 17301167 DOI: 10.1523/JNEUROSCI.5112-06.2007 |
0.642 |
|
| 2007 |
Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. The Journal of Clinical Investigation. 117: 672-82. PMID 17290303 DOI: 10.1172/JCI30413 |
0.669 |
|
| 2007 |
Apud JA, Mattay V, Chen J, Kolachana BS, Callicott JH, Rasetti R, Alce G, Iudicello JE, Akbar N, Egan MF, Goldberg TE, Weinberger DR. Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1011-20. PMID 17063156 DOI: 10.1038/sj.npp.1301227 |
0.643 |
|
| 2007 |
Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, Egan MF, Rujescu D, Weinberger DR. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Human Genetics. 120: 889-906. PMID 17006672 DOI: 10.1007/s00439-006-0257-3 |
0.428 |
|
| 2006 |
Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Archives of General Psychiatry. 63: 1396-406. PMID 17146014 DOI: 10.1001/Archpsyc.63.12.1396 |
0.429 |
|
| 2006 |
Nicodemus KK, Luna A, Vakkalanka R, Goldberg T, Egan M, Straub RE, Weinberger DR. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Molecular Psychiatry. 11: 1062-5. PMID 17130882 DOI: 10.1038/sj.mp.4001878 |
0.434 |
|
| 2006 |
Tan HY, Sust S, Buckholtz JW, Mattay VS, Meyer-Lindenberg A, Egan MF, Weinberger DR, Callicott JH. Dysfunctional prefrontal regional specialization and compensation in schizophrenia. The American Journal of Psychiatry. 163: 1969-77. PMID 17074949 DOI: 10.1176/appi.ajp.163.11.1969 |
0.634 |
|
| 2006 |
Winterer G, Musso F, Beckmann C, Mattay V, Egan MF, Jones DW, Callicott JH, Coppola R, Weinberger DR. Instability of prefrontal signal processing in schizophrenia. The American Journal of Psychiatry. 163: 1960-8. PMID 17074948 DOI: 10.1176/appi.ajp.163.11.1960 |
0.628 |
|
| 2006 |
Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR. Impact of complex genetic variation in COMT on human brain function. Molecular Psychiatry. 11: 867-77, 797. PMID 16786032 DOI: 10.1038/sj.mp.4001860 |
0.62 |
|
| 2006 |
Winterer G, Egan MF, Kolachana BS, Goldberg TE, Coppola R, Weinberger DR. Prefrontal electrophysiologic "noise" and catechol-O-methyltransferase genotype in schizophrenia. Biological Psychiatry. 60: 578-84. PMID 16730334 DOI: 10.1016/j.biopsych.2006.03.023 |
0.444 |
|
| 2006 |
Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, Egan MF, Gill M, Kendler KS, Kirov G, Heston LL, et al. Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biological Psychiatry. 60: 152-62. PMID 16631129 DOI: 10.1016/J.Biopsych.2006.02.015 |
0.353 |
|
| 2006 |
Marenco S, Steele SU, Egan MF, Goldberg TE, Straub RE, Sharrief AZ, Weinberger DR. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. The American Journal of Psychiatry. 163: 740-2. PMID 16585454 DOI: 10.1176/appi.ajp.163.4.740 |
0.439 |
|
| 2006 |
Meyer-Lindenberg A, Buckholtz JW, Kolachana B, R Hariri A, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proceedings of the National Academy of Sciences of the United States of America. 103: 6269-74. PMID 16569698 DOI: 10.1073/pnas.0511311103 |
0.598 |
|
| 2006 |
Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, Coppola R, Egan MF, Weinberger DR. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2022-32. PMID 16554747 DOI: 10.1038/sj.npp.1301049 |
0.628 |
|
| 2006 |
Chrapusta SJ, Egan MF. Poor evidence for depolarization block but uncoupling of nigral from striatal dopamine metabolism after chronic haloperidol treatment in the rat. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 573-82. PMID 16082510 DOI: 10.1007/s00702-005-0347-8 |
0.308 |
|
| 2006 |
Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR. COMT haplotype variation affects human prefrontal function Molecular Psychiatry. 11: 797. DOI: 10.1038/sj.mp.4001881 |
0.488 |
|
| 2006 |
Pezawas L, Goldman A, Verchinski B, Mattay V, Callicott J, Kolachana B, Straub R, Egan M, Meyer-Lindenberg A, Weinberger D. P.2.b.017 Biologic epistasis between SERT and BDNF: complex genetic mechanisms of depression European Neuropsychopharmacology. 16: S310-S311. DOI: 10.1016/S0924-977X(06)70331-5 |
0.506 |
|
| 2005 |
Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, Goldberg TE, Weinberger DR. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 102: 8627-32. PMID 15939883 DOI: 10.1073/pnas.0500515102 |
0.667 |
|
| 2005 |
Blasi G, Mattay VS, Bertolino A, Elvevåg B, Callicott JH, Das S, Kolachana BS, Egan MF, Goldberg TE, Weinberger DR. Effect of catechol-O-methyltransferase val158met genotype on attentional control. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5038-45. PMID 15901785 DOI: 10.1523/JNEUROSCI.0476-05.2005 |
0.616 |
|
| 2005 |
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience. 8: 828-34. PMID 15880108 DOI: 10.1038/Nn1463 |
0.332 |
|
| 2005 |
Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, Berman KF. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Archives of General Psychiatry. 62: 379-86. PMID 15809405 DOI: 10.1001/Archpsyc.62.4.379 |
0.486 |
|
| 2004 |
Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10099-102. PMID 15537879 DOI: 10.1523/JNEUROSCI.2680-04.2004 |
0.617 |
|
| 2004 |
Weickert TW, Goldberg TE, Mishara A, Apud JA, Kolachana BS, Egan MF, Weinberger DR. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biological Psychiatry. 56: 677-82. PMID 15522252 DOI: 10.1016/j.biopsych.2004.08.012 |
0.471 |
|
| 2004 |
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics. 75: 807-21. PMID 15457404 DOI: 10.1086/425589 |
0.412 |
|
| 2004 |
Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 101: 12604-9. PMID 15310849 DOI: 10.1073/Pnas.0405077101 |
0.619 |
|
| 2004 |
Winterer G, Coppola R, Goldberg TE, Egan MF, Jones DW, Sanchez CE, Weinberger DR. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia. The American Journal of Psychiatry. 161: 490-500. PMID 14992975 DOI: 10.1176/appi.ajp.161.3.490 |
0.488 |
|
| 2004 |
Goldberg T, Egan M, Straub R, Weinberger D. S.19.02 Cognitive genomics and schizophrenia:Implications for drug targets European Neuropsychopharmacology. 14: S148. DOI: 10.1016/S0924-977X(04)80058-0 |
0.362 |
|
| 2003 |
Winterer G, Coppola R, Egan MF, Goldberg TE, Weinberger DR. Functional and effective frontotemporal connectivity and genetic risk for schizophrenia. Biological Psychiatry. 54: 1181-92. PMID 14643085 DOI: 10.1016/S0006-3223(03)00532-8 |
0.478 |
|
| 2003 |
Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. The American Journal of Psychiatry. 160: 2209-15. PMID 14638592 DOI: 10.1176/appi.ajp.160.12.2209 |
0.679 |
|
| 2003 |
Winterer G, Egan MF, Raedler T, Sanchez C, Jones DW, Coppola R, Weinberger DR. P300 and genetic risk for schizophrenia. Archives of General Psychiatry. 60: 1158-67. PMID 14609891 DOI: 10.1001/archpsyc.60.11.1158 |
0.406 |
|
| 2003 |
Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry. 60: 889-96. PMID 12963670 DOI: 10.1001/Archpsyc.60.9.889 |
0.351 |
|
| 2003 |
Apud JA, Egan MF, Wyatt RJ. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. Schizophrenia Research. 63: 151-60. PMID 12892869 DOI: 10.1016/S0920-9964(02)00338-9 |
0.462 |
|
| 2003 |
Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6690-4. PMID 12890761 DOI: 10.1523/Jneurosci.23-17-06690.2003 |
0.547 |
|
| 2003 |
Weickert TW, Goldberg TE, Marenco S, Bigelow LB, Egan MF, Weinberger DR. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1491-500. PMID 12799617 DOI: 10.1038/sj.npp.1300216 |
0.375 |
|
| 2003 |
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America. 100: 6186-91. PMID 12716966 DOI: 10.1073/pnas.0931309100 |
0.649 |
|
| 2003 |
Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, Weinberger DR. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. The American Journal of Psychiatry. 160: 709-19. PMID 12668360 DOI: 10.1176/appi.ajp.160.4.709 |
0.701 |
|
| 2003 |
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 112: 257-69. PMID 12553913 DOI: 10.1016/S0092-8674(03)00035-7 |
0.53 |
|
| 2003 |
Chrapusta SJ, Egan MF, Wyatt RJ, Weinberger DR, Lipska BK. Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. Synapse (New York, N.Y.). 47: 270-7. PMID 12539200 DOI: 10.1002/Syn.10179 |
0.482 |
|
| 2003 |
Raedler TJ, Knable MB, Jones DW, Urbina RA, Gorey JG, Lee KS, Egan MF, Coppola R, Weinberger DR. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. The American Journal of Psychiatry. 160: 118-27. PMID 12505810 DOI: 10.1176/appi.ajp.160.1.118 |
0.479 |
|
| 2003 |
Egan MF, Goldberg TE. Intermediate cognitive phenotypes associated with schizophrenia. Methods in Molecular Medicine. 77: 163-97. PMID 12298369 DOI: 10.1385/1-59259-348-8:163 |
0.42 |
|
| 2002 |
Weickert TW, Terrazas A, Bigelow LB, Malley JD, Hyde T, Egan MF, Weinberger DR, Goldberg TE. Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learning & Memory (Cold Spring Harbor, N.Y.). 9: 430-42. PMID 12464703 DOI: 10.1101/lm.49102 |
0.383 |
|
| 2002 |
Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. Serotonin transporter genetic variation and the response of the human amygdala. Science (New York, N.Y.). 297: 400-3. PMID 12130784 DOI: 10.1126/Science.1071829 |
0.309 |
|
| 2002 |
Hamid EH, Hyde TM, Egan MF, Wolf SS, Herman MM, Nemeroff CB, Kleinman JE. Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders. Biological Psychiatry. 51: 795-800. PMID 12007453 DOI: 10.1016/S0006-3223(01)01325-7 |
0.401 |
|
| 2002 |
Weinberger D, Egan MF, Bertolino A, Callicott JH, Mattay V, Lipska BK, Berman KF, Goldberg TE. Erratum: Prefrontal Neurons and the Genetics of Schizophrenia (Biological Psychiatry, Vol 50:11 (825-844)) Biological Psychiatry. 51. DOI: 10.1016/S0006-3223(01)01372-5 |
0.605 |
|
| 2001 |
Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE. Prefrontal neurons and the genetics of schizophrenia. Biological Psychiatry. 50: 825-44. PMID 11743939 DOI: 10.1016/S0006-3223(01)01252-5 |
0.704 |
|
| 2001 |
Egan MF, Hyde TM, Bonomo JB, Mattay VS, Bigelow LB, Goldberg TE, Weinberger DR. Relative risk of neurological signs in siblings of patients with schizophrenia. The American Journal of Psychiatry. 158: 1827-34. PMID 11691688 DOI: 10.1176/appi.ajp.158.11.1827 |
0.466 |
|
| 2001 |
Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR, Berman KF. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. The American Journal of Psychiatry. 158: 1809-17. PMID 11691686 DOI: 10.1176/Appi.Ajp.158.11.1809 |
0.466 |
|
| 2001 |
Winterer G, Egan MF, Rädler T, Coppola R, Weinberger DR. Event-related potentials and genetic risk for schizophrenia. Biological Psychiatry. 50: 407-17. PMID 11566157 DOI: 10.1016/S0006-3223(01)01072-1 |
0.383 |
|
| 2001 |
Egan MF, Goldberg TE, Gscheidle T, Weirich M, Rawlings R, Hyde TM, Bigelow L, Weinberger DR. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biological Psychiatry. 50: 98-107. PMID 11527000 DOI: 10.1016/S0006-3223(01)01133-7 |
0.327 |
|
| 2001 |
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 98: 6917-22. PMID 11381111 DOI: 10.1073/Pnas.111134598 |
0.701 |
|
| 2001 |
Winterer G, Egan MF, Rädler T, Hyde T, Coppola R, Weinberger DR. An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia. Schizophrenia Research. 49: 129-43. PMID 11343872 DOI: 10.1016/S0920-9964(00)00128-6 |
0.404 |
|
| 2001 |
Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, Weinberger DR. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biological Psychiatry. 49: 39-46. PMID 11163778 DOI: 10.1016/S0006-3223(00)00997-5 |
0.671 |
|
| 2001 |
Dawson NM, Hamid EH, Egan MF, Meredith GE. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment. Synapse (New York, N.Y.). 39: 70-81. PMID 11071712 DOI: 10.1002/1098-2396(20010101)39:1<70::AID-SYN10>3.0.CO;2-J |
0.321 |
|
| 2001 |
Winterer G, Egan MF, Rädler T, Hyde T, Coppola R, Weinberger DR. Erratum to: “An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia” [Schizophr. Res. 49 (2001) 129–143] Schizophrenia Research. 51: 181. DOI: 10.1016/S0920-9964(01)00274-2 |
0.375 |
|
| 2000 |
Goldberg TE, Dodge M, Aloia M, Egan MF, Weinberger DR. Effects of neuroleptic medications on speech disorganization in schizophrenia: biasing associative networks towards meaning. Psychological Medicine. 30: 1123-30. PMID 12027048 DOI: 10.1017/S0033291799002639 |
0.353 |
|
| 2000 |
Elvevåg B, Egan MF, Goldberg TE. Memory for temporal order in patients with schizophrenia. Schizophrenia Research. 46: 187-93. PMID 11120430 DOI: 10.1016/S0920-9964(00)00014-1 |
0.386 |
|
| 2000 |
Apud JA, Egan MF, Wyatt RJ. Effects of smoking during antipsychotic withdrawal in patients with chronic schizophrenia. Schizophrenia Research. 46: 119-27. PMID 11120424 DOI: 10.1016/S0920-9964(99)00230-3 |
0.436 |
|
| 2000 |
Elvevåg B, Egan MF, Goldberg TE. Paired-associate learning and memory interference in schizophrenia. Neuropsychologia. 38: 1565-75. PMID 11074079 DOI: 10.1016/S0028-3932(00)00074-9 |
0.383 |
|
| 2000 |
Callicott JH, Bertolino A, Egan MF, Mattay VS, Langheim FJ, Weinberger DR. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. The American Journal of Psychiatry. 157: 1646-51. PMID 11007719 DOI: 10.1176/appi.ajp.157.10.1646 |
0.657 |
|
| 2000 |
Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Archives of General Psychiatry. 57: 907-13. PMID 10986554 DOI: 10.1001/Archpsyc.57.9.907 |
0.453 |
|
| 2000 |
Egan MF, Goldberg TE, Gscheidle T, Weirich M, Bigelow LB, Weinberger DR. Relative risk of attention deficits in siblings of patients with schizophrenia. The American Journal of Psychiatry. 157: 1309-16. PMID 10910796 DOI: 10.1176/appi.ajp.157.8.1309 |
0.382 |
|
| 2000 |
Raedler TJ, Knable MB, Jones DW, Lafargue T, Urbina RA, Egan MF, Pickar D, Weinberger DR. In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 56-68. PMID 10869886 DOI: 10.1016/S0893-133X(99)00162-1 |
0.375 |
|
| 2000 |
Japee S, Meyer-Lindenberg A, Verchinski B, Kohn P, Egan M, Bigelow L, Callicott J, Bertolino A, Mattay V, Weinberger D, Berman K. Development of a template-based quantitative volumetric method: Application to structural MRI data from schizophrenic patients, their siblings and normal controls Neuroimage. 11: S545. DOI: 10.1016/S1053-8119(00)91476-9 |
0.552 |
|
| 2000 |
Holt JL, Meyer-Lindenberg A, Callicott J, Van Horn JD, Egan M, Weinberger D, Berman KF. Abnormalities of dorsolateral prefrontal activation in patients with schizophrenia at two time points during a medication-free period: Single-subject and group analyses Neuroimage. 11: S229. DOI: 10.1016/S1053-8119(00)91161-3 |
0.639 |
|
| 2000 |
Verchinski B, Meyer-Lindenberg A, Japee S, Kohn P, Egan M, Bigelow L, Callicott J, Bertolino A, Mattay V, Berman K, Weinberger D. Gender differences in gray matter density: A study of structural mri images using voxel-based morphometry Neuroimage. 11: S228. DOI: 10.1016/S1053-8119(00)91160-1 |
0.525 |
|
| 2000 |
Meyer-Lindenberg A, Japee S, Verchinski B, Kohn P, Egan M, Bigelow L, Callicott J, Bertolino A, Mattay V, Berman KF, Weinberger D. Structural MRI abnormalities in schizophrenic patients and their unaffected siblings: Voxel-based morphometry Neuroimage. 11: S217. DOI: 10.1016/S1053-8119(00)91149-2 |
0.57 |
|
| 2000 |
Meyer-Lindenberg A, Kohn P, Holt J, Egan M, Weinberger D, Berman K. Disturbed connectivity in schizophrenia: PET studies Neuroimage. 11: S186. DOI: 10.1016/S1053-8119(00)91119-4 |
0.414 |
|
| 2000 |
Callicott J, Egan M, Mattay V, Bertolino A, Bone A, Weinberger D. Prefrontal cortex inefficiency: Potential intermediate phenotype in schizophrenics and their siblings Schizophrenia Research. 41: 89. DOI: 10.1016/S0920-9964(00)90511-5 |
0.564 |
|
| 2000 |
Weinberger D, Bertolino A, Callicott J, Egan M, Esposito G, Mattay V, Brier A, Knable M, Berman K. 214. Studies of prefrontal cortical functional connectivity in schizophrenia Biological Psychiatry. 47: S65. DOI: 10.1016/S0006-3223(00)00478-9 |
0.669 |
|
| 2000 |
Meyer-Lindenberg A, Holt J, Egan M, Weinberger D, Berman K. 212. Task-independent and task-dependent disturbances in functional connectivity in schizophrenia: pet studies Biological Psychiatry. 47: S64-S65. DOI: 10.1016/S0006-3223(00)00476-5 |
0.362 |
|
| 2000 |
Meyer-Lindenberg A, Kohn P, Holt J, Egan M, Weinberger D, Berman KF. Disturbed connectivity in schizophrenia: PET studies Neuroimage. 11: S186. |
0.301 |
|
| 1999 |
Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. The American Journal of Psychiatry. 156: 1646-9. PMID 10518181 DOI: 10.1176/Ajp.156.10.1646 |
0.419 |
|
| 1998 |
Callicott JH, Egan MF, Bertolino A, Mattay VS, Langheim FJ, Frank JA, Weinberger DR. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biological Psychiatry. 44: 941-50. PMID 9821558 DOI: 10.1016/S0006-3223(98)00264-9 |
0.681 |
|
| 1998 |
Baca SM, Lipska BK, Egan MF, Bachus SE, Ferguson JN, Hyde TM. Effects of prefrontal cortical lesions on neuropeptide and dopamine receptor gene expression in the striatum-accumbens complex. Brain Research. 797: 55-64. PMID 9630515 DOI: 10.1016/S0006-8993(98)00343-6 |
0.353 |
|
| 1998 |
Callicott J, Egan M, Mattay V, Bertolino A, Jones K, Goldberg T, Weinberger D. Altered prefrontal cortical function in unaffected siblings of patients with schizophrenia Neuroimage. 7: S895. DOI: 10.1016/S1053-8119(18)31728-2 |
0.678 |
|
| 1998 |
Callicott JH, Egan MF, Mattay VS, Bertolino A, Jones KM, Goldberg TE, Weinberger DR. Altered prefrontal cortical function in unaffected siblings of patients with schizophrenia Neuroimage. 7: S895. |
0.646 |
|
| 1997 |
Egan MF, Weinberger DR. Neurobiology of schizophrenia. Current Opinion in Neurobiology. 7: 701-7. PMID 9384552 DOI: 10.1016/S0959-4388(97)80092-X |
0.411 |
|
| 1997 |
Egan MF, Apud J, Wyatt RJ. Treatment of tardive dyskinesia. Schizophrenia Bulletin. 23: 583-609. PMID 9365997 DOI: 10.1093/Schbul/23.4.583 |
0.456 |
|
| 1997 |
Bachus SE, Hyde TM, Herman MM, Egan MF, Kleinman JE. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. Journal of Psychiatric Research. 31: 233-56. PMID 9278188 DOI: 10.1016/S0022-3956(96)00041-6 |
0.418 |
|
| 1996 |
Egan MF, Chrapusta S, Karoum F, Lipska BK, Wyatt RJ. Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 777-805. PMID 8872864 DOI: 10.1007/BF01273358 |
0.414 |
|
| 1996 |
Egan MF, Chrapusta SJ, Karoum F, Wyatt RJ. The effects of acute and chronic haloperidol treatment on dopamine release mediated by the medial forebrain bundle in the striatum and nucleus accumbens. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 211-23. PMID 8866705 DOI: 10.1016/0893-133X(95)00111-P |
0.474 |
|
| 1995 |
Egan MF, Hyde TM, Kleinman JE, Wyatt RJ. Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose. Psychopharmacology. 117: 74-81. PMID 7724705 DOI: 10.1007/BF02245101 |
0.403 |
|
| 1995 |
Hyde TM, Egan MF, Wing LL, Wyatt RJ, Weinberger DR, Kleinman JE. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate. Psychopharmacology. 118: 142-9. PMID 7617800 DOI: 10.1007/BF02245832 |
0.438 |
|
| 1995 |
Bartzokis G, Marder SR, Elkashef AM, Egan MF, Frank JA, Hyde TM, Lewis BK, Wyatt RJ. Magnetic resonance imaging evaluation of brain iron levels Biological Psychiatry. 38: 133-135. PMID 7578650 DOI: 10.1016/0006-3223(95)00036-G |
0.324 |
|
| 1994 |
Karoum F, Egan MF, Wyatt RJ. Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposure. European Journal of Pharmacology. 254: 127-32. PMID 8206108 DOI: 10.1016/0014-2999(94)90379-4 |
0.389 |
|
| 1994 |
Elkashef AM, Egan MF, Frank JA, Hyde TM, Lewis BK, Wyatt RJ. Basal ganglia iron in tardive dyskinesia: an MRI study. Biological Psychiatry. 35: 16-21. PMID 8167198 DOI: 10.1016/0006-3223(94)91161-4 |
0.457 |
|
| 1994 |
Knable MB, Hyde TM, Egan MF, Tosayali M, Wyatt RJ, Kleinman JE. Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements. Brain Research. 646: 217-22. PMID 8069667 DOI: 10.1016/0006-8993(94)90081-7 |
0.424 |
|
| 1994 |
Karoum F, Chrapusta SJ, Egan MF. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Journal of Neurochemistry. 63: 972-9. PMID 7914228 DOI: 10.1046/J.1471-4159.1994.63030972.X |
0.354 |
|
| 1994 |
Egan MF, Duncan CC, Suddath RL, Kirch DG, Mirsky AF, Wyatt RJ. Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia. Schizophrenia Research. 11: 259-71. PMID 7910755 DOI: 10.1016/0920-9964(94)90020-5 |
0.509 |
|
| 1994 |
Chrapusta SJ, Egan MF, Masserano JM, Wyatt RJ. Dopamine release in the rat cerebellum and hippocampus: a tissue 3-methoxytyramine study. Brain Research. 655: 271-5. PMID 7812787 DOI: 10.1016/0006-8993(94)91627-6 |
0.49 |
|
| 1994 |
Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse (New York, N.Y.). 18: 178-89. PMID 7531873 DOI: 10.1002/syn.890180303 |
0.44 |
|
| 1994 |
Egan MF, Wing L, Li R, Kirch DG, Wyatt RJ. Effects of chronic cocaine treatment on rat brain: long-term reduction in frontal cortical serotonin. Biological Psychiatry. 36: 637-40. PMID 7530497 DOI: 10.1016/0006-3223(94)90079-5 |
0.361 |
|
| 1993 |
Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ. Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release. European Journal of Pharmacology. 233: 135-42. PMID 8472742 DOI: 10.1016/0014-2999(93)90359-P |
0.462 |
|
| 1993 |
Karoum F, Chrapusta SJ, Egan MF, Wyatt RJ. Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study. Journal of Neurochemistry. 61: 1369-75. PMID 8104232 DOI: 10.1111/J.1471-4159.1993.Tb13630.X |
0.47 |
|
| 1993 |
Egan MF, Dargham AA, Kirch DG, Wyatt RJ. Serum creatine phosphokinase elevations in patients with tardive dyskinesia. The British Journal of Psychiatry : the Journal of Mental Science. 162: 551-3. PMID 8097656 DOI: 10.1192/Bjp.162.4.551 |
0.415 |
|
| 1993 |
Wyatt R, Egan M, Karoum F, Masserano J, Chrapusta S, Hitri A. A biochemical comparison of long-term cocaine administration and schizophrenia Schizophrenia Research. 9: 230. DOI: 10.1016/0920-9964(93)90507-F |
0.424 |
|
| 1993 |
Wing LL, Elkashef A, Kirch DG, Egan MF, Hyde TM, Wyatt RJ, Kulaga H. CD5+ B lymphocytes and the effects of continuous haloperidol decanoate and coenzyme-q10: An animal model of immunologic anomalies in schizophrenia Schizophrenia Research. 9: 229. DOI: 10.1016/0920-9964(93)90506-E |
0.35 |
|
| 1992 |
Egan MF, Hyde TM, Tirschwell DL, Kleinman JE, Weinberger DR. Laterality of appendicular tardive dyskinesia in chronic schizophrenia. Biological Psychiatry. 31: 1098-109. PMID 1525274 DOI: 10.1016/0006-3223(92)90154-R |
0.344 |
|
| 1992 |
Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ. gamma-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions. European Journal of Pharmacology. 222: 129-35. PMID 1468488 DOI: 10.1016/0014-2999(92)90472-G |
0.462 |
|
| 1992 |
Egan MF, el-Mallakh RS, Suddath RL, Lohr JB, Bracha HS, Wyatt RJ. Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia. Psychiatry Research. 43: 187-95. PMID 1357702 DOI: 10.1016/0165-1781(92)90133-N |
0.479 |
|
| 1992 |
Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ. Treatment of tardive dyskinesia with vitamin E. The American Journal of Psychiatry. 149: 773-7. PMID 1350428 DOI: 10.1176/Ajp.149.6.773 |
0.392 |
|
| 1991 |
Egan MF, Karoum F, Wyatt RJ. Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum. European Journal of Pharmacology. 199: 191-9. PMID 1954977 DOI: 10.1016/0014-2999(91)90457-2 |
0.461 |
|
| 1991 |
Gold JM, Egan MF, Kirch DG, Goldberg TE, Daniel DG, Bigelow LB, Wyatt RJ. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings. Biological Psychiatry. 30: 587-99. PMID 1681948 DOI: 10.1016/0006-3223(91)90028-K |
0.431 |
|
| 1988 |
Wyatt RJ, Alexander RC, Egan MF, Kirch DG. Schizophrenia, just the facts. What do we know, how well do we know it? Schizophrenia Research. 1: 3-18. PMID 3154503 DOI: 10.1016/0920-9964(88)90034-5 |
0.498 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
Weickert T, Goldberg T, Egan M, Weinberger D. ISTIC CATEGORY LEARNING DEFICITS EXIST IN A SUBSET OF UNAFFECTED SIBLINGS OF PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 102: 131. DOI: 10.1016/S0920-9964(08)70399-2 |
0.298 |
|
| 1993 |
EGAN MF, HYDE TM, ELKASHEF A, WYATT RJ. Dr. Egan and Colleagues Reply American Journal of Psychiatry. 150: 992-993. DOI: 10.1176/Ajp.150.6.992 |
0.298 |
|
| 2013 |
Egan MF, Zhao X, Gottwald R, Harper-Mozley L, Zhang Y, Snavely D, Lines C, Michelson D. Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia Schizophrenia Research. 146: 224-230. PMID 23523692 DOI: 10.1016/j.schres.2013.02.030 |
0.296 |
|
| 2003 |
Weickert TW, Goldberg TE, Marenco S, Bigelow LB, Egan MF, Weinberger DR. Erratum: Comparison of Cognitive Peformances During a Placebo Period and an Atypical Antipsychotic Treatment Period in Schizophrenia: Critical Examination of Confounds Neuropsychopharmacology. 28: 2217-2217. DOI: 10.1038/sj.npp.1300349 |
0.294 |
|
| 1996 |
Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology. 127: 337-45. PMID 8923569 DOI: 10.1007/S002130050095 |
0.293 |
|
| 1998 |
Hamid EH, Hyde TM, Baca SM, Egan MF. Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia. Brain Research. 796: 291-5. PMID 9689480 DOI: 10.1016/S0006-8993(98)00196-6 |
0.292 |
|
| 2003 |
Egan MF, Weinberger DR, Lu B. Schizophrenia, III: brain-derived neurotropic factor and genetic risk. The American Journal of Psychiatry. 160: 1242. PMID 12832235 DOI: 10.1176/APPI.AJP.160.7.1242 |
0.289 |
|
| 1997 |
Knable MB, Egan MF, Heinz A, Gorey J, Lee KS, Coppola R, Weinberger DR. Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study. The British Journal of Psychiatry : the Journal of Mental Science. 171: 574-7. PMID 9519100 DOI: 10.1192/Bjp.171.6.574 |
0.283 |
|
| 1995 |
Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse (New York, N.Y.). 20: 125-30. PMID 7570341 DOI: 10.1002/syn.890200205 |
0.279 |
|
| 1995 |
Hyde TM, Egan MF, Brown RJ, Weinberger DR, Kleinman JE. Diurnal variation in tardive dyskinesia. Psychiatry Research. 56: 53-7. PMID 7792342 DOI: 10.1016/0165-1781(94)02662-3 |
0.279 |
|
| 2007 |
Genderson MR, Dickinson D, Diaz-Asper CM, Egan MF, Weinberger DR, Goldberg TE. Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophrenia Research. 94: 231-9. PMID 17570645 DOI: 10.1016/J.Schres.2006.12.031 |
0.275 |
|
| 2003 |
Nicolson R, Brookner FB, Lenane M, Gochman P, Ingraham LJ, Egan MF, Kendler KS, Pickar D, Weinberger DR, Rapoport JL. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. The American Journal of Psychiatry. 160: 490-5. PMID 12611830 DOI: 10.1176/Appi.Ajp.160.3.490 |
0.275 |
|
| 2000 |
Raedler T, Knable M, Jones D, Urbina R, Gorey J, Lee K, Egan M, Weinberger D. Reduced central muscarinic acetylcholine receptor availability in vivo in schizophrenic patients European Neuropsychopharmacology. 10: 298. DOI: 10.1016/S0924-977X(00)80329-6 |
0.27 |
|
| 1999 |
Raedler T, Knable M, Urbina R, Jones D, Egan M, Coppola R, Weinberger D. Central muscarinic cholinergic receptor availability in patients treated with clozapine European Neuropsychopharmacology. 9: 298. DOI: 10.1016/S0924-977X(99)80374-5 |
0.264 |
|
| 1995 |
Egan MF, Ferguson JN, Hyde TM. Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate. Brain Research Bulletin. 38: 355-63. PMID 8535858 DOI: 10.1016/0361-9230(95)00108-Q |
0.264 |
|
| 2000 |
Egan MF, Goldberg TE, Gscheidle T, Bigelow L, Weinberger DR. Heritability estimates for independent domains of cognitive dysfunction in schizophrenia Schizophrenia Research. 41: 89-90. DOI: 10.1016/S0920-9964(00)90513-9 |
0.262 |
|
| 1996 |
Egan MF, Ferguson J, Hyde TM. Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements. Pharmacology, Biochemistry, and Behavior. 53: 401-10. PMID 8808150 DOI: 10.1016/0091-3057(95)02041-1 |
0.26 |
|
| 2000 |
Bower CM, Hyde TM, Zaka M, Hamid EH, Baca SM, Egan MF. Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol. Psychopharmacology. 150: 260-3. PMID 10923753 DOI: 10.1007/s002130000460 |
0.257 |
|
| 2018 |
Ursini G, Punzi G, Chen Q, Marenco S, Robinson JF, Porcelli A, Hamilton E, Mitjans M, Maddalena G, Begemann M, Seidel J, Yanamori H, Jaffe AE, Berman KF, Egan MF, et al. O4.7. PLACENTAL GENE EXPRESSION, OBSTETRICAL HISTORY AND POLYGENIC RISK FOR SCHIZOPHRENIA Schizophrenia Bulletin. 44: S85-S86. DOI: 10.1093/Schbul/Sby015.213 |
0.254 |
|
| 2008 |
Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. MET BDNF protects against morphological S allele effects of 5-HTTLPR Molecular Psychiatry. 13: 654. DOI: 10.1038/mp.2008.61 |
0.253 |
|
| 2002 |
Marenco S, Egan MF, Goldberg TE, Knable MB, McClure RK, Winterer G, Weinberger DR. Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series. Schizophrenia Research. 57: 221-6. PMID 12223253 DOI: 10.1016/S0920-9964(01)00311-5 |
0.242 |
|
| 1993 |
Karoum F, Chrapusta S, Egan M. Combined gas chromatography—mass spectrometry for the analysis of central and peripheral biogenic amines Techniques in the Behavioral and Neural Sciences. 11: 127-149. DOI: 10.1016/B978-0-444-81369-5.50009-2 |
0.237 |
|
| 2013 |
Egan MF, Zhao X, Smith A, Troyer MD, Uebele VN, Pidkorytov V, Cox K, Murphy M, Snavely D, Lines C, Michelson D. Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia. Human Psychopharmacology. 28: 124-33. PMID 23532746 DOI: 10.1002/hup.2289 |
0.237 |
|
| 2005 |
Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR. A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry. 62: 146-52. PMID 15699291 DOI: 10.1001/Archpsyc.62.2.146 |
0.229 |
|
| 1993 |
Gupta S, Egan MF, Hyde TM. An unusual presentation of tardive dyskinesia with prominent involvement of the pectoral musculature. Biological Psychiatry. 33: 291-2. PMID 8097115 DOI: 10.1016/0006-3223(93)90297-Q |
0.227 |
|
| 1992 |
Karoum F, Egan MF. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol. British Journal of Pharmacology. 105: 703-7. PMID 1628156 |
0.225 |
|
| 2003 |
Raedler TJ, Knable MB, Jones DW, Urbina RA, Egan MF, Weinberger DR. Central muscarinic acetylcholine receptor availability in patients treated with clozapine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1531-7. PMID 12799613 DOI: 10.1038/sj.npp.1300210 |
0.224 |
|
| 2012 |
Hornig M, Briese T, Licinio J, Khabbaz RF, Altshuler LL, Potkin SG, Schwemmle M, Siemetzki U, Mintz J, Honkavuori K, Kraemer HC, Egan MF, Whybrow PC, Bunney WE, Lipkin WI. Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Molecular Psychiatry. 17: 486-93. PMID 22290118 DOI: 10.1038/Mp.2011.179 |
0.195 |
|
| 2005 |
Sporn A, Greenstein D, Gogtay N, Sailer F, Hommer DW, Rawlings R, Nicolson R, Egan MF, Lenane M, Gochman P, Weinberger DR, Rapoport JL. Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members. Schizophrenia Research. 73: 243-52. PMID 15653267 DOI: 10.1016/J.Schres.2004.07.020 |
0.189 |
|
| 2020 |
Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, ... Egan MF, et al. BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain. Brain : a Journal of Neurology. PMID 33253354 DOI: 10.1093/brain/awaa332 |
0.164 |
|
| 1998 |
Hamid E, Hyde T, Egan M, Bachus S, Kinkead B, Nemeroff C, Wolf S, Herman M, Kleinman J. Abnormalities in neurotensin gene expression levels in the hippocampus of schizophrenics Schizophrenia Research. 29: 102-103. DOI: 10.1016/S0920-9964(97)88560-X |
0.157 |
|
| 2000 |
Meredith GE, De Souza IE, Hyde TM, Tipper G, Wong ML, Egan MF. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 7798-806. PMID 11027244 |
0.151 |
|
| 1999 |
Raedler TJ, Knable MB, Lafargue T, Urbina RA, Egan MF, Pickar D, Weinberger DR. In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine. Psychiatry Research. 90: 81-90. PMID 10482380 DOI: 10.1016/S0925-4927(99)00010-4 |
0.145 |
|
| 2005 |
Egan MF. Neuroimaging the genetic effects of brain-derived neurotrophic factor on human hippocampus Dialogues in Clinical Neuroscience. 7: 136-138. |
0.143 |
|
| 2013 |
Hostetler ED, Sanabria-Bohórquez S, Eng W, Joshi AD, Patel S, Gibson RE, O'Malley S, Krause SM, Ryan C, Riffel K, Bi S, Okamoto O, Kawamoto H, Ozaki S, Ohta H, ... ... Egan M, et al. Evaluation of [¹â¸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human. Neuroimage. 68: 1-10. PMID 23238431 DOI: 10.1016/J.Neuroimage.2012.11.053 |
0.14 |
|
| 2012 |
Egan M, Yaari R, Liu L, Ryan M, Peng Y, Lines C, Michelson D. Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD. Current Alzheimer Research. 9: 481-90. PMID 22272611 |
0.133 |
|
| 1993 |
Egan M, Chrapusta S, Karoum F, Wyatt R. Evidence against depolarization block hypothesis of the mechanism of action of antipsychotic drugs: Effects of tetrodotoxin infusion into the median forebrain bundle after acute and chronic neuroleptic treatment Schizophrenia Research. 9: 218. DOI: 10.1016/0920-9964(93)90472-U |
0.131 |
|
| 1998 |
Hamid EH, Egan MF, Dickson LA. Detrimental effects of short term haloperidol treatment and withdrawal on striatal BDNF gene expression Faseb Journal. 12: A758. |
0.108 |
|
| 1993 |
Fegan M, Manners JM, Maclean DJ, Irwin JA, Samuels KD, Holdom DG, Li DP. Random amplified polymorphic DNA markers reveal a high degree of genetic diversity in the entomopathogenic fungus Metarhizium anisopliae var. anisopliae. Journal of General Microbiology. 139: 2075-81. PMID 8245834 |
0.103 |
|
| 1989 |
Gold J, Egan M, Goldberg T, Kirch D. Cognitive impairment and tardive dyskinesia Schizophrenia Research. 2: 236. DOI: 10.1016/0920-9964(89)90272-7 |
0.095 |
|
| 2000 |
Goldberg TE, Dodge M, Egan MF, Aloia M, Weinberger DR. Neuroleptic medication, priming, and thought disorder: Evidence for an effect on associative networks Schizophrenia Research. 41: 53-54. DOI: 10.1016/S0920-9964(00)90419-5 |
0.089 |
|
| 2020 |
Wessels AM, Lines C, Stern RA, Kost J, Voss T, Mozley LH, Furtek C, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, Dupre N, Randolph C, Michelson D, ... ... Egan MF, et al. Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33049114 DOI: 10.1002/alz.12164 |
0.086 |
|
| 2018 |
Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D. Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease. The New England Journal of Medicine. 378: 1691-1703. PMID 29719179 DOI: 10.1056/Nejmoa1706441 |
0.083 |
|
| 1998 |
Hamid E, Baca S, Meredith G, Hyde T, Egan M. 113. Neuroleptic drug effects on synaptophysin gene expression levels Biological Psychiatry. 43: S34. DOI: 10.1016/S0006-3223(98)90561-3 |
0.081 |
|
| 2016 |
Kennedy ME, Stamford AW, Chen X, Cox K, Cumming JN, Dockendorf MF, Egan M, Ereshefsky L, Hodgson RA, Hyde LA, Jhee S, Kleijn HJ, Kuvelkar R, Li W, Mattson BA, et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients. Science Translational Medicine. 8: 363ra150. PMID 27807285 DOI: 10.1126/scitranslmed.aad9704 |
0.08 |
|
| 2023 |
Tucker MA, Schipper AM, Adams TSF, Attias N, Avgar T, Babic NL, Barker KJ, Bastille-Rousseau G, Behr DM, Belant JL, Beyer DE, Blaum N, Blount JD, Bockmühl D, Pires Boulhosa RL, ... ... Egan M, et al. Behavioral responses of terrestrial mammals to COVID-19 lockdowns. Science (New York, N.Y.). 380: 1059-1064. PMID 37289888 DOI: 10.1126/science.abo6499 |
0.076 |
|
| 2013 |
Allyn J, Guglielminotti J, Omnes S, Guezouli L, Egan M, Jondeau G, Longrois D, Montravers P. Marfan's syndrome during pregnancy: anesthetic management of delivery in 16 consecutive patients. Anesthesia and Analgesia. 116: 392-8. PMID 23302979 DOI: 10.1213/ANE.0b013e3182768f78 |
0.075 |
|
| 2018 |
Voss T, Li J, Cummings J, Farlow M, Assaid C, Froman S, Leibensperger H, Snow-Adami L, McMahon KB, Egan M, Michelson D. Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 173-181. PMID 29955661 DOI: 10.1016/J.Trci.2018.03.004 |
0.065 |
|
| 2022 |
Sur C, Adamczuk K, Scott D, Kost J, Sampat M, Buckley C, Farrar G, Newton B, Suhy J, Bennacef I, Egan MF. Evaluation of F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease. Molecular Imaging and Biology. PMID 35794343 DOI: 10.1007/s11307-022-01735-z |
0.064 |
|
| 2020 |
Sergott RC, Raji A, Kost J, Sur C, Jackson S, Locco A, Patel A, Furtek C, Mattson B, Egan MF. Retinal Optical Coherence Tomography Metrics are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy. Journal of Alzheimer's Disease : Jad. PMID 33252075 DOI: 10.3233/JAD-200735 |
0.061 |
|
| 2015 |
Young JW, Potter WZ, Riley S, Groeneveld GJ, Kinon BJ, Egan MF, Feltner DE. Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium. Innovations in Clinical Neuroscience. 12: 5S-10S. PMID 25977839 |
0.058 |
|
| 2008 |
Young JM, Allen C, Coutinho T, Denny T, Elphinstone J, Fegan M, Gillings M, Gottwald TR, Graham JH, Iacobellis NS, Janse JD, Jacques MA, Lopez MM, Morris CE, Parkinson N, et al. Plant-pathogenic bacteria as biological weapons - real threats? Phytopathology. 98: 1060-5. PMID 18943451 DOI: 10.1094/Phyto-98-10-1060 |
0.054 |
|
| 2017 |
Mo Y, Stromswold J, Wilson K, Holder D, Sur C, Laterza O, Savage MJ, Struyk A, Scheltens P, Teunissen CE, Burke J, Macaulay SL, Bråthen G, Sando SB, White LR, ... ... Egan MF, et al. A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 201-209. PMID 28349119 DOI: 10.1016/J.Dadm.2017.02.004 |
0.049 |
|
| 2023 |
Mulryan K, O'Connor J, Egan M, Redmond K. Tracheobronchomalacia: an unusual cause of debilitating dyspnoea and its surgical management. Bmj Case Reports. 16. PMID 37977838 DOI: 10.1136/bcr-2022-254229 |
0.048 |
|
| 2015 |
Daurat A, Choquet O, Bringuier S, Charbit J, Egan M, Capdevila X. Diagnosis of Postoperative Urinary Retention Using a Simplified Ultrasound Bladder Measurement. Anesthesia and Analgesia. 120: 1033-8. PMID 25642660 DOI: 10.1213/ANE.0000000000000595 |
0.043 |
|
| 2019 |
Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, et al. Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease. The New England Journal of Medicine. 380: 1408-1420. PMID 30970186 DOI: 10.1056/Nejmoa1812840 |
0.043 |
|
| 1992 |
Ei-Mallakh RS, Egan M, Jed Wyatt R. Creatine Kinase and Enolase: Intracellular Enzymes Serving as Markers of Central Nervous System Damage in Neuropsychiatric Disorders. Psychiatry. 55: 392-402. PMID 27707363 DOI: 10.1080/00332747.1992.11024612 |
0.042 |
|
| 2019 |
Egan MF, Mukai Y, Voss T, Kost J, Stone J, Furtek C, Mahoney E, Cummings JL, Tariot PN, Aisen PS, Vellas B, Lines C, Michelson D. Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease. Alzheimer's Research & Therapy. 11: 68. PMID 31387606 DOI: 10.1186/S13195-019-0520-1 |
0.041 |
|
| 2000 |
Franke IH, Fegan M, Hayward C, Leonard G, Sly LI. Molecular detection of Gluconacetobacter sacchari associated with the pink sugarcane mealybug Saccharicoccus sacchari (Cockerell) and the sugarcane leaf sheath microenvironment by FISH and PCR. Fems Microbiology Ecology. 31: 61-71. PMID 10620720 |
0.041 |
|
| 2010 |
Remenant B, Coupat-Goutaland B, Guidot A, Cellier G, Wicker E, Allen C, Fegan M, Pruvost O, Elbaz M, Calteau A, Salvignol G, Mornico D, Mangenot S, Barbe V, Médigue C, et al. Genomes of three tomato pathogens within the Ralstonia solanacearum species complex reveal significant evolutionary divergence. Bmc Genomics. 11: 379. PMID 20550686 DOI: 10.1186/1471-2164-11-379 |
0.039 |
|
| 2014 |
Bernard R, Salvi N, Gall O, Egan M, Treluyer JM, Carli PA, Orliaguet GA. MORPHIT: an observational study on morphine titration in the postanesthetic care unit in children. Paediatric Anaesthesia. 24: 303-8. PMID 24205822 DOI: 10.1111/pan.12286 |
0.033 |
|
| 2019 |
O'Callaghan TF, Mannion D, Apopei D, McCarthy NA, Hogan SA, Kilcawley KN, Egan M. Influence of Supplemental Feed Choice for Pasture-Based Cows on the Fatty Acid and Volatile Profile of Milk. Foods (Basel, Switzerland). 8. PMID 31013643 DOI: 10.3390/foods8040137 |
0.032 |
|
| 2012 |
Egan M. Barry Commoner's place in history. Science (New York, N.Y.). 338: 1028. PMID 23180843 DOI: 10.1126/science.338.6110.1028-a |
0.032 |
|
| 2022 |
Dockendorf MF, Jaworowicz D, Humphrey R, Anderson M, Breidinger S, Ma L, Taylor T, Dupre N, Jones C, Furtek C, Kantesaria B, Bateman KP, Woolf E, Egan MF, Stone JA. A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials. The Aaps Journal. 24: 53. PMID 35384522 DOI: 10.1208/s12248-022-00682-5 |
0.032 |
|
| 1999 |
Wen A, Fegan M, Hayward C, Chakraborty S, Sly LI. Phylogenetic relationships among members of the Comamonadaceae, and description of Delftia acidovorans (den Dooren de Jong 1926 and Tamaoka et al. 1987) gen. nov., comb. nov International Journal of Systematic Bacteriology. 49: 567-576. PMID 10319477 |
0.03 |
|
| 2006 |
Rehberger D, Fegan M, Kornbluh M. Reevaluating access and preservation through secondary repositories; needs, promises, and challenges Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 4172: 39-50. |
0.028 |
|
| 2009 |
Spearman P, Kalams S, Elizaga M, Metch B, Chiu YL, Allen M, Weinhold KJ, Ferrari G, Parker SD, McElrath MJ, Frey SE, Fuchs JD, Keefer MC, Lubeck MD, Egan M, et al. Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial. Vaccine. 27: 243-9. PMID 18996425 DOI: 10.1016/J.Vaccine.2008.10.051 |
0.027 |
|
| 2015 |
Schotola H, Kirsch KC, Höcker J, Egan M, Büttner B, Wiese C, Mansur A, Hinz JM, Bergmann I. Ketamine in outpatient arthroscopic shoulder surgery: Effects on postoperative pain, hemodynamic stability and process times. Open Medicine (Warsaw, Poland). 10: 297-305. PMID 28352709 DOI: 10.1515/med-2015-0043 |
0.027 |
|
| 2007 |
Ridge JP, Lin M, Larsen EI, Fegan M, McEwan AG, Sly LI. A multicopper oxidase is essential for manganese oxidation and laccase-like activity in Pedomicrobium sp. ACM 3067. Environmental Microbiology. 9: 944-53. PMID 17359266 DOI: 10.1111/j.1462-2920.2006.01216.x |
0.025 |
|
| 2015 |
Bagley K, Xu R, Ota-Setlik A, Egan M, Schwartz J, Fouts T. The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses. Human Vaccines & Immunotherapeutics. 11: 2228-40. PMID 26042527 DOI: 10.1080/21645515.2015.1026498 |
0.024 |
|
| 2004 |
Kornbluh M, Fegan M, Rehberger D. Media matrix: Creating secondary repositories Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 3232: 329-340. |
0.022 |
|
| 2002 |
Egan M, Goldman D, Weinberger D. The human genome: mutations American Journal of Psychiatry. 159: 12. PMID 11772682 DOI: 10.1176/Appi.Ajp.159.1.12 |
0.021 |
|
| 2023 |
Wilson GJ, Rodriguez B, Li SS, Allen M, Frank I, Rudnicki E, Trahey M, Kalams S, Hannaman D, Clarke DK, Xu R, Egan M, Eldridge J, Pensiero M, Latham T, et al. Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial. Vaccine. PMID 36935288 DOI: 10.1016/j.vaccine.2023.03.015 |
0.02 |
|
| 2010 |
Bondar A, Egan M, Jochum D, Amarenco G, Bouaziz H. Case report: pudendal nerve injury after a sciatic nerve block by the posterior approach. Anesthesia and Analgesia. 111: 573-5. PMID 20584876 DOI: 10.1213/ANE.0b013e3181e36994 |
0.019 |
|
| 2015 |
Marshall JA, Lynch SE, Crowder JC, Catton MG, Fegan M, Bruggink LD. Electron microscope detection of tubular aggregates in the mosquito cell line C6/36 treated with Culex australicus (mosquito) homogenate. Microscopy (Oxford, England). PMID 26323477 DOI: 10.1093/jmicro/dfv051 |
0.018 |
|
| 2014 |
Orliaguet GA, Gall O, Egan M, Salvi N, Bernard R, Treluyer JM, Carli PA. Response to Voepel-Lewis and Malviya's comment 'pain score guided morphine titration is risky and inappropriate'. Paediatric Anaesthesia. 24: 641-2. PMID 24809840 DOI: 10.1111/pan.12407 |
0.016 |
|
| 2023 |
Voss T, Kost J, Mercer SP, Furtek C, Randolph C, Lines C, Egan MF, Cummings JL. Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions. Journal of Alzheimer's Disease : Jad. PMID 36744336 DOI: 10.3233/JAD-220836 |
0.014 |
|
| 2019 |
Kennedy ME, Egan MF. Verubecestat for Prodromal Alzheimer's Disease. Reply. The New England Journal of Medicine. 381: 389. PMID 31340106 DOI: 10.1056/NEJMc1906679 |
0.014 |
|
| 2009 |
Shields N, White M, Egan M. [Battlefield Blues: Ambivalence about treatment among military Veterans with depression]. Canadian Family Physician MéDecin De Famille Canadien. 55: 799-802. PMID 19675264 |
0.013 |
|
| 2021 |
Srinivasan K, Egan M. From airway 'grading' to 'coding'. European Journal of Anaesthesiology. 38: 205-206. PMID 33394803 DOI: 10.1097/EJA.0000000000001314 |
0.011 |
|
| 2002 |
Sherry E, Egan M, Henderson A, Warnke PH. Minimally invasive techniques for total hip arthroplasty. The Journal of Bone and Joint Surgery. American Volume. 84: 1481; author reply 1. PMID 12177284 |
0.011 |
|
| 2003 |
Sherry E, Egan M, Warnke PH, Henderson A, Eslick GD. Minimal invasive surgery for hip replacement: a new technique using the NILNAV hip system. Anz Journal of Surgery. 73: 157-61. PMID 12608981 |
0.01 |
|
| 2022 |
Safavi D, Subramaniam VS, Obeidi N, Egan M, Abu Saadeh F. Post-operative ureteral injury after cytoreductive surgery for ovarian cancer managed by primary repair through minimally invasive approach. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 36446411 DOI: 10.1136/ijgc-2022-003963 |
0.01 |
|
| 1999 |
Franke IH, Fegan M, Hayward C, Leonard G, Stackebrandt E, Sly LI. Description of Gluconacetobacter sacchari sp. nov., a new species of acetic acid bacterium isolated from the leaf sheath of sugar cane and from the pink sugar-cane mealy bug. International Journal of Systematic Bacteriology. 49: 1681-93. PMID 10555349 |
0.01 |
|
| Hide low-probability matches. |